How many employees does I-Mab have this year?
I-Mab has 185 undefined employees this year.
I-Mab Employees 2025
I-Mab Employees
185
Ticker
IMAB
ISIN
US44975P1030
WKN
A2PVC6
In 2025, I-Mab employed 185 people, a 0% change from the 185 number of employees in the previous year.
I-Mab Aktienanalyse
What does I-Mab do?
I-Mab is a Chinese biopharmaceutical company specializing in the development of innovative therapies for the treatment of cancer and autoimmune diseases. It was founded in 2016 by Dr. Jingwu Zang and is based in Shanghai, China. I-Mab's business model focuses on the development of antibody therapies tailored to the needs of cancer and autoimmune patients. They utilize the latest research and development to create therapies that address the unmet market demand. They work on cancer immunotherapy, including CAR-T cell therapy, and also on immunotherapy for autoimmune diseases, including rare ones. Their goal is to improve the lives of patients with cancer and autoimmune diseases through innovative biotechnology and research. They have promising products in development and clinical trials, such as AMG 228 and TJM2. They aim to make a significant contribution to healthcare with their dedicated team of researchers and scientists. I-Mab ist eines der beliebtesten Unternehmen auf Eulerpool.com.Employees Details
Examining I-Mab's Employee Base
I-Mab's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding I-Mab's operational capacity and future potential.
Year-to-Year Comparison
Assessing I-Mab's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.
Impact on Investments
I-Mab's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.
Interpreting Employee Trends
Fluctuations in I-Mab’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.
Frequently Asked Questions about I-Mab stock
How many employees did I-Mab have compared to the previous year?
Compared to the previous year, I-Mab had 0% more employees.
What impact did the number of employees have on the company I-Mab?
The number of employees has a direct impact on the efficiency and productivity of I-Mab. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.
What impact did the number of employees have on investors of I-Mab?
The number of employees can also have an impact on investors of I-Mab, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.
How does an increase in equity capital of I-Mab affect the company?
An increase in equity of I-Mab can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.
How does a reduction in I-Mab's equity affect the company?
A reduction in equity of I-Mab can impair its financial stability and decrease its ability to fulfill future investments and obligations.
What are some factors that influence the equity of I-Mab?
Some factors that can influence the equity of I-Mab include, among others, revenue development, profit and loss statement, dividend payments, and investments.
Why is the equity of I-Mab so important for investors?
The equity of I-Mab is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.
How does the number of employees at I-Mab influence the company?
The number of employees at I-Mab can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.
How has the number of employees at I-Mab evolved in recent years?
In recent years, the number of employees at I-Mab has changed by 0.
How many employees does I-Mab currently have?
I-Mab currently has 185 undefined employees.
Why is the number of employees important for investors of I-Mab?
The number of employees is important for investors of I-Mab as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.
What strategic measures can I-Mab take to change the number of employees?
To change the number of employees, I-Mab can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.
How much dividend does I-Mab pay?
Over the past 12 months, I-Mab paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, I-Mab is expected to pay a dividend of 0 USD.
What is the dividend yield of I-Mab?
The current dividend yield of I-Mab is .
When does I-Mab pay dividends?
I-Mab pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of I-Mab?
I-Mab paid dividends every year for the past 0 years.
What is the dividend of I-Mab?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is I-Mab located?
I-Mab is assigned to the 'Health' sector.
Wann musste ich die Aktien von I-Mab kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of I-Mab from 10/17/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/17/2025.
When did I-Mab pay the last dividend?
The last dividend was paid out on 10/17/2025.
What was the dividend of I-Mab in the year 2024?
In the year 2024, I-Mab distributed 0 USD as dividends.
In which currency does I-Mab pay out the dividend?
The dividends of I-Mab are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von I-Mab
Our stock analysis for I-Mab Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of I-Mab Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
